CEPHALON (NASDAQ:CEPH)
59.61
0.1 (0.17%)
| CEPHALON (NASDAQ:CEPH) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $59.71 | 52 Week High | $81.35 | ||
| Open | $59.39 | 52 Week Low | $52.55 | ||
| Day High | $60.00 | P/E | 18.06 | ||
| Day Low | $59.38 | EPS | $3.30 | ||
| Volume | 1,941,477 | ||||
| More CEPH Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| FRX | 6 | ACL | 4 |
| AGN | 4 | MRX | 4 |
| ENDP | 4 | SEPR | 4 |
| TEVA | 3 | MYL | 3 |
| VCLK | 3 | KG | 3 |
| GET | 2 | ADM | 2 |
Entities who have mentioned CEPH
- Dividend | View Related Stories »
- Soleil Securities | View Related Stories »
- Citi | View Related Stories »
- Deutsche Bank | View Related Stories »
- JPMorgan | View Related Stories »
- Scopia Capital | View Related Stories »
- Goldman Sachs | View Related Stories »
- UBS | View Related Stories »
- Trading Radar | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- Twitter | View Related Stories »
- American Technology Research | View Related Stories »
- Standard & Poor's | View Related Stories »
- After-Hours Movers | View Related Stories »
- Merrill Lynch | View Related Stories »
- Notable Mergers and Acquisitions | View Related Stories »
- Piper Jaffray | View Related Stories »
- Robert W Baird | View Related Stories »
- Barclays | View Related Stories »
- Natixis Bleichroeder | View Related Stories »
- Banc of America | View Related Stories »
- Pending Home Sales | View Related Stories »
- BMO Capital | View Related Stories »
- RBC Capital | View Related Stories »
- Jefferies & Co | View Related Stories »
View All Major News StreetInsider.com Major News for CEPH
- Cephalon (CEPH) Tops Q3 EPS by 20c, Revs Light; Guides FY10 EPS Above the Street
- Cephalon (CEPH) Tops Q2 EPS by 26c; Issues Mixed Guidance for Q3 and FY
- Cephalon (CEPH) Tops Q1 EPS By 20c; Updates 2009 Guidance
View All ReportsStreetInsider.com Reports on CEPH
- Soleil Securities Reiterates a 'Buy' on Cephalon (CEPH)
- Cephalon (CEPH) Tops Q3 EPS by 20c, Revs Light; Guides FY10 EPS Above the Street
- Trading Radar for 10/27: Visa (V), Baidu.com (BIDU), WYNN Resorts (WYNN), RF Micro (RFMD), BP (BP) Report
- Cephalon (CEPH) Signs Option Agreement to Acquire BioAssets Development Corp.
- Baird Downgraded Cubist Pharmaceuticals (CBST) and Cephalon (CEPH) to Neutral On Challenging Growth
View All Press ReleasesCompany Press Releases on CEPH
- Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkin's Lymphoma
- Cephalon, Inc. to Webcast R&D Day
- Mayo Clinic Proceedings Publishes Study of NUVIGIL in Patients with Shift Work Disorder
- Trading Review for Jazz Pharmaceuticals Inc. Issued by Beacon Equity
- Cephalon Net Sales Increase 9% and Net Cash from Operations Surpasses $200 Million in the Third Quarter 2009
StreetInsider Reports on CEPH by Category
View All BlogsBlogs on CEPH
- Biotech Stocks for a Possible Year-End Rally
- Monday Options Update: GLD, AMR, ANF, CEPH & ESV
- Cephalon's Upside and Downside
- Wall Street Breakfast: Must-Know News
- Thursday Options Recap
View All FilingsSEC Filings on CEPH
- Form 8-K CEPHALON INC For: Nov 18
- Form 8-K CEPHALON INC For: Nov 02
- Form 10-Q CEPHALON INC For: Sep 30
- Form 8-K CEPHALON INC For: Oct 27
- Form 8-K CEPHALON INC For: Oct 26
Comments on recent CEPH articles
Comments on CEPH
No comments are currently available.
on Oct 28, 2009
at 05:29 PM ANDREW OLIVER SATCHELL GOOD
Article: Trading Radar for 10/27: Visa (V), Baidu.com (BIDU), WYNN Resorts (WYNN), RF Micro (RFMD), BP (BP) Report